COXIBRAIN: results of the prospective, randomised, phase II/III study for the selective COX-2 inhibition in chronic subdural haematoma patients
Crossref DOI link: https://doi.org/10.1007/s00701-016-2949-3
Published Online: 2016-09-07
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schaumann, A. http://orcid.org/0000-0001-5656-2588
Klene, W.
Rosenstengel, Chr.
Ringel, F.
Tüttenberg, J.
Vajkoczy, P.
Funding for this research was provided by:
NeuroCure Cluster of Excellence
License valid from 2016-09-07